Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
2025 · New England Journal of Medicine · 40 citations
https://doi.org/10.1056/nejmoa2505133
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
52
Citations
2
h-index
2
i10-index
Andrea Pieragostini is an academic researcher from Acute Leukemia French Association. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment & Protein Degradation and Inhibitors. The author has an h-index of 2, co-authored 5 publications.
Click to start Chat